Cisplatin and Continuous Infusion of Fluorouracil Followed by Radiation and Weekly Carboplatin in the Treatment of Locally Advanced Head and Neck Cancer: A Hellenic Cooperative Oncology Group Study

References

• Dasmahapatra K S, Citrin P, Hill G J, et al. A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck. J Clin 1985; 3: 1486–1489
   Google Scholar
• Rooney M, Kish J, Jacobs J, et al. Improved complete response rate and survival in advanced head and neck cancer after the three-course induction therapy with 120-hours 5-FU infusion therapy and cisplatin. Cancer 1985; 55: 1123–1128
   PubMed Web of Science ®Google Scholar
• Ensley J, Kish J, Tapazoglou E, et al. An intensive, five course alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer. J Clin Oncol 1986; 6: 1147–1153
   Web of Science ®Google Scholar
• Verweij J, DeJong P C, DeMulder P HM, et al. Induction chemotherapy with cisplatin and continuous infusion 5-fluorouracil in locally far-advanced head and neck cancer. Am J Clin Oncol 1989; 12: 420–424
   PubMed Web of Science ®Google Scholar
• Bernal A G, Cruz J J, Sanchez P, et al. Four-day continuous infusion of cisplatin and 5-fluorouracil in head and neck cancer. Cancer 1989; 63: 1927–1930
   PubMed Web of Science ®Google Scholar
• Yokes E E, Moran W J, Mick R, et al. Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer. J Clin Oncol 1989; 7: 838–845
   PubMed Web of Science ®Google Scholar
• Yokes E E, Schilsky R L, Weichelbaum R R, et al. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: A clinical and pharmacologic analysis. J Clin Oncol 1990; 8: 241–247
   PubMed Web of Science ®Google Scholar
• Fountzilas G, Daniilidis J, Sridhar K S, et al. Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region. Cancer 1990; 66: 1453–1460
   PubMed Web of Science ®Google Scholar
• Fountzilas G, Kosmidis P, Makrantonakis P, et al. Carboplatin, continuous infusion 5-fluorouracil and mid-cycle high dose methotrexate as initial treatment in patients with locally advanced head and neck cancer. Tumori 1991; 77: 426–431
   PubMed Web of Science ®Google Scholar
• American Joint Committee on Cancer. Manual for Staging on Cancer, 3rd ed. JB Lippincott, Philadelphia 1988; 27–51
   Google Scholar
• Sridhar K S, Donnelly E. Combination antiemetics for cisplatin chemotherapy. Cancer 1988; 61: 1508–1517
   PubMed Web of Science ®Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation for incomplete observations. J Am Statist Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 1966; 50: 163–170
   PubMedGoogle Scholar
• Douple E B, Richmond R C, O'Hara J A, et al. Carboplatin as a potentiation of radiation therapy. Cancer Treat Rev 1985; 12(Suppl A)111–124
   PubMed Web of Science ®Google Scholar
• O'Hara J A, Douple E B, Richmond R C, et al. Enhancement of radiation-induced cell kill by platinum complexes (Carboplatin and iproplatin) in V79 cells. Int J Radiat Oncol Biol Phys 1986; 12: 1419–1422
   PubMed Web of Science ®Google Scholar
• Douple E B. Keynote address: Platinum-radiation interactions. NCI Monogr 1988; 6: 315–319
   PubMedGoogle Scholar
• Coughlin C T, Richmond R C. Biologic and clinical developments of cisplatin combined with radiation: Concepts, utility, projection for new trials, and the emergence of Carboplatin. Semin Oncol 1989; 16(Suppl 6)31–43
   PubMed Web of Science ®Google Scholar
• Creagen E T, Fountain K S, Frytal S, et al. Concomitant radiation therapy and cis-diammine-dichloroplatinum in patients with advanced head and neck cancer. Med Pediatr Oncol 1981; 9: 119–120
   PubMedGoogle Scholar
• Leipzig B. Cisplatin sensitization to radiotherapy of squamous cell carcinoma of the head and neck. Am J Surg 1983; 146: 462–465
   PubMed Web of Science ®Google Scholar
• Coughlin C T, Richmond R C. Platinum based combined modality approach for locally advanced head and neck carcinoma. Int J Radiat Oncol Biol Phys 1985; 11: 915–919
   PubMed Web of Science ®Google Scholar
• Marcial V A, Pajak T F, Mohiuddin M, et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck: Long-term results of the Radiation Therapy Oncology Group Study 81–17. Cancer 1990; 66: 1861–1868
   PubMed Web of Science ®Google Scholar
• Eisenberger M, Sinibaldi V, Jacobs M, et al. Simultaneous treatment with Carboplatin (NSC-241–240) and radiotherapy in advanced unresectable squamous cell carcinoma of the head and neck. Cancer Treat Rev 1988; 15(Suppl B)3–7
   PubMed Web of Science ®Google Scholar
• Shaphshay S M, Hong W K, Incze J S, et al. Prognostic indicators in induction cis-platinum, bleomycin chemotherapy for advanced head and neck cancer. Am J Surg 1980; 140: 534–548
   Web of Science ®Google Scholar
• Cognetti F, Pinnaro P, Ruggeri E M, et al. Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer. J Clin Oncol 1989; 7: 829–837
   PubMed Web of Science ®Google Scholar
• Davis R K, Stoker K, Harker G, et al. Prognostic indicators in head and neck cancer patients receiving combined therapy. Arch Otolaryngol Head Neck Surg 1989; 115: 1443–1446
   PubMed Web of Science ®Google Scholar
• Fountzilas G, Kosmidis P, Beer M, et al. Factors influencing complete response and survival in patients with head and neck cancer treated with platinum-based induction chemotherapy: A Hellenic Co-operative Oncology Group Study. Ann Oncol 1992; 3: 553–558
   PubMed Web of Science ®Google Scholar
• Fountzilas G, Daniilidis J, Kosmidis P, et al. Platinum-based induction chemotherapy followed by radiation as definitive treatment for patients with locally advanced cancer of the oral cavity, oropharynx and hypopharynx: A retrospective analysis of 32 cases. J Chemother 1991; 3: 183–188
   PubMed Web of Science ®Google Scholar
• Nikolaou A, Fountzilas G, Kosmidis P, et al. Laryngeal preservation in cases of advanced laryngeal cancer treated with platinum based induction chemotherapy before local treatment. J Laryngol Otol 1991; 105: 930–933
   PubMed Web of Science ®Google Scholar
• Paccagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Naü Cancer Inst 1994; 86: 265–272
   PubMed Web of Science ®Google Scholar
• Pfister D G, Strong E, Harrison L, et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 1991; 9: 850–859
   PubMed Web of Science ®Google Scholar
• Urba S G, Forastiere A A, Wolf G T, et al. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. J Clin Oncol 1994; 12: 946–953
   PubMed Web of Science ®Google Scholar
• Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685–1690
   PubMed Web of Science ®Google Scholar
• Freeman N J, Costanza M E. 5-Fluorouracil-associated cardiotoxicity. Cancer 1988; 61: 36–45
   PubMed Web of Science ®Google Scholar
• Labianca R, Beretta G, Clerisi M, et al. Cardiac toxicity of 5-fluorouracil: A study of 1083 patients. Tumori 1982; 68: 505–510
   PubMed Web of Science ®Google Scholar
• Liss R H, Chadwick M. Correlation of 5-fluorouracil distribution in rodents with toxicity and chemotherapy in man. Cancer Chemother Rep 1974; 58: 777–786
   PubMedGoogle Scholar
• Suzuki T, Nakanishi H, Hayashi A, et al. Cardiac toxicity of 5-fluorouracil in rabbits. Jpn J Pharmacol 1972; 27(Suppl)137
   Google Scholar
• Ervin T J, Clark J R, Weichselbaum R R, et al. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 1987; 5: 10–20
   PubMed Web of Science ®Google Scholar
• Fountzilas G, Daniilidis J, Sridhar K S, et al. Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region. Cancer 1990; 66: 1453–1460
   PubMed Web of Science ®Google Scholar